← Back to Screener
InnovAge Holding Corp. Common Stock (INNV)
Price$7.30
Value ScoreD
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)30.33%
Price vs S&P 500 (4W)-3.56%
VGM Score46.25
Market Capitalization$990.88M
All Metrics
P/CF (Annual)30.15x
Book Value / Share (Quarterly)$1.69
P/TBV (Annual)2.16x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)6.91%
Cash Flow / Share (Quarterly)$0.31
Price vs S&P 500 (YTD)32.50%
Gross Margin (TTM)21.75%
Net Profit Margin (TTM)-1.22%
EPS (TTM)$-0.09
10-Day Avg Trading Volume0.29M
EPS Excl Extra (TTM)$-0.09
Revenue Growth (5Y)8.52%
EPS (Annual)$-0.22
ROI (Annual)-9.86%
Gross Margin (Annual)18.00%
Net Profit Margin (5Y Avg)-4.02%
Cash / Share (Quarterly)$1.02
P/E Basic Excl Extra (TTM)154.52x
Revenue Growth QoQ (YoY)15.49%
ROA (Last FY)-5.75%
Revenue Growth TTM (YoY)14.13%
EBITD / Share (TTM)$0.06
ROE (5Y Avg)-9.93%
Operating Margin (TTM)-1.02%
Cash Flow / Share (Annual)$0.20
P/B Ratio4.33x
P/B Ratio (Quarterly)4.75x
Net Income / Employee (Annual)$-12,400
EV / Revenue (TTM)1.02x
Net Interest Coverage (TTM)-4.67x
ROA (TTM)-2.20%
EV / EBITDA (TTM)112.29x
EPS Incl Extra (Annual)$-0.22
Current Ratio (Annual)1.07x
Quick Ratio (Quarterly)0.87x
3-Month Avg Trading Volume0.32M
52-Week Price Return83.88%
EV / Free Cash Flow (Annual)36.23x
P/E Incl Extra (TTM)154.52x
Revenue / Employee (TTM)$389,000
Tangible BV / Share (Quarterly)$1.66
P/S Ratio (Annual)1.16x
Asset Turnover (Annual)1.62x
52-Week High$10.69
Operating Margin (5Y Avg)-3.71%
EPS Excl Extra (Annual)$-0.22
CapEx CAGR (5Y)-11.96%
26-Week Price Return38.26%
Quick Ratio (Annual)0.92x
13-Week Price Return-23.40%
Total Debt / Equity (Annual)0.31x
Current Ratio (Quarterly)1.03x
Enterprise Value$963.91M
Revenue / Share Growth (5Y)8.17%
Asset Turnover (TTM)1.80x
Revenue / Employee (Annual)$349,900
Pretax Margin (Annual)-3.99%
Cash / Share (Annual)$0.78
3-Month Return Std Dev47.65%
Gross Margin (5Y Avg)19.34%
Net Income / Employee (TTM)$-4,800
EBITDA Interim CAGR (5Y)-5.15%
ROE (Last FY)-12.90%
Net Interest Coverage (Annual)-1.35x
EPS Basic Excl Extra (Annual)$-0.22
P/FCF (TTM)23.20x
Receivables Turnover (TTM)26.01x
EV / Free Cash Flow (TTM)22.69x
Total Debt / Equity (Quarterly)0.30x
EPS Incl Extra (TTM)$-0.09
Receivables Turnover (Annual)20.21x
ROI (TTM)-3.73%
P/S Ratio (TTM)1.04x
Pretax Margin (5Y Avg)-4.15%
Revenue / Share (Annual)$6.31
Tangible BV / Share (Annual)$1.71
Forward P/E19.66x
Free OCF CAGR (5Y)-3.62%
Price vs S&P 500 (52W)59.51%
P/E Ratio (TTM)154.52x
Year-to-Date Return40.66%
5-Day Price Return0.00%
EPS Normalized (Annual)$-0.22
ROA (5Y Avg)-5.25%
Net Profit Margin (Annual)-3.55%
Month-to-Date Return-3.82%
Cash Flow / Share (TTM)$-0.18
EBITD / Share (Annual)$-0.08
Operating Margin (Annual)-3.49%
LT Debt / Equity (Annual)0.24x
P/CF (TTM)18.93x
ROI (5Y Avg)-7.73%
P/E Excl Extra (TTM)154.52x
LT Debt / Equity (Quarterly)0.24x
EPS Basic Excl Extra (TTM)$-0.09
P/TBV (Quarterly)4.82x
P/B Ratio (Annual)2.13x
Pretax Margin (TTM)-1.43%
Book Value / Share (Annual)$1.73
Price vs S&P 500 (13W)-31.65%
Beta0.47x
P/FCF (Annual)37.25x
Revenue / Share (TTM)$6.99
ROE (TTM)-4.81%
52-Week Low$3.13
vGradeD
gGradeC
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q3 26-0.22est. 0.06
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
2.33
2.33
2.33
2.33
Industry Peers — Health Services(21)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
INNVInnovAge Holding Corp. Common Stock | D | C | C | $7.30 |
| LFSTLifeStance Health Group, Inc. Common Stock | D | B | C | $7.41 |
| PRVAPrivia Health Group, Inc. Common Stock | D | B | D | $21.63 |
| WGSGeneDx Holdings Corp. Class A Common Stock | F | B | D | $52.21 |
| PNTGThe Pennant Group, Inc. Common Stock | C | B | C | $31.71 |
| OMDAOmada Health, Inc. Common Stock | D | A | B | $17.93 |
| USPHUS Physical Therapy Inc | C | C | D | $63.45 |
| TALKTalkspace, Inc. Common Stock | F | B | B | $5.22 |
| SRTAStrata Critical Medical, Inc. Class A Common Stock | C | A | B | $5.79 |
| ALPSALPS Group Inc Ordinary Share | — | — | F | $0.71 |
| PIIIP3 Health Partners Inc. Common Stock | A | C | B | $11.58 |
About
InnovAge operates a capitated healthcare platform serving high-cost seniors, including dual-eligible beneficiaries, through its PACE (Program of All-Inclusive Care for the Elderly) model. The company's participant-centered approach delivers integrated care while keeping seniors independent at home, reducing costly hospital and nursing home admissions. This model addresses rising U.S. healthcare costs while improving care quality and outcomes.